Marketwatch Pfizer Inc’s CEO offloaded 62% of his stock holdings post Covid-19 vaccine trial success announcement Admin November 11, 2020 In an SEC filing on late Tuesday, Bourla disclosed that he has sold 62 per cent of his stock holdings, or 1,32,508 shares, at $41.94 per share. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
